Pneumococcal wall teichoic acid is required for the pathogenesis of Streptococcus pneumoniae in murine models

Journal of Microbiology

Volumn 53, Issue 2, 2015, Pages 147-154

  Xu, Hongmei ^a   Wang, Libin ^a   Huang, Jian ^a   Zhang, Yanqing ^a   Ma, Feng ^a   Wang, Jianmin ^a   Xu, Wenchun ^a   Zhang, Xuemei ^a   Yin, Yibing ^a   Wu, Kaifeng ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

colonization; pathogenesis; Streptococcus pneumoniae; wall teichoic acid

Indexed keywords

BACTERIA (MICROORGANISMS); MURINAE; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C3; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TEICHOIC ACID;

ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG; MICROBIOLOGY; MOUSE; MUTATION; NASOPHARYNX; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE; ULTRASTRUCTURE; VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; COMPLEMENT C3; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; MUTATION; NASOPHARYNX; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TEICHOIC ACIDS; VIRULENCE;

EID: 84921905525     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-015-4616-4     Document Type: Article

References (27)

1. Bogaert, D., de Groot, R., and Hermans, P.W.M. 2004. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect. Dis.4, 144–154.
2. Bui, N.K., Eberhardt, A., Vollmer, D., Kern, T., Bougault, C., Tomasz, A., Simorre, J.P., and Vollmer, W. 2012. Isolation and analysis of cell wall components from Streptococcus pneumoniae. Anal. Biochem.421, 657–666.
3. Cundell, D.R., Gerard, N.P., Gerard, C., Idanpaan-Heikkila, I., and Tuomanen, E.I. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature377, 435–438.
4. Draing, C., Pfitzenmaier, M., Zummo, S., Mancuso, G., Geyer, A., Hartung, T., and von Aulock, S. 2006. Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae. J. Biol. Chem.281, 33849–33859.
5. Gehre, F., Spisek, R., Kharat, A.S., Matthews, P., Kukreja, A., Anthony, R.M., Dhodapkar, M.V., Vollmer, W., and Tomasz, A. 2009. Role of teichoic acid choline moieties in the virulence of Streptococcus pneumoniae. Infect. Immun.77, 2824–2831.
6. Gisch, N., Kohler, T., Ulmer, A.J., Muthing, J., Pribyl, T., Fischer, K., Lindner, B., Hammerschmidt, S., and Zahringer, U. 2013. Structural reevaluation of Streptococcus pneumoniae lipoteichoic acid and new insights into its immunostimulatory potency. J. Biol. Chem.288, 15654–15667.
7. Grundling, A. and Schneewind, O. 2007. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA104, 8478–8483.
8. Hammerschmidt, S., Wolff, S., Hocke, A., Rosseau, S., Muller, E., and Rohde, M. 2005. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect. Immun.73, 4653–4667.
9. Hsu, H.E., Shutt, K.A., Moore, M.R., Beall, B.W., Bennett, N.M., Craig, A.S., Farley, M.M., Jorgensen, J.H., Lexau, C.A., Petit, S.,et al. 2009. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl. J. Med.360, 144–156.
10. Hummell, D.S., Swift, A.J., Tomasz, A., and Winkelstein, J.A. 1985. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid. Infect. Immun.47, 384–387.
11. Kadioglu, A., Weiser, J.N., Paton, J.C., and Andrew, P.W. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol.6, 288–301.
12. Kawai, Y., Marles-Wright, J., Cleverley, R. M., Emmins, R., Ishikawa, S., Kuwano, M., Heinz, N., Bui, N.K., Hoyland, C.N., Ogasawara, N.,et al. 2011. A widespread family of bacterial cell wall assembly proteins. EMBO J.30, 4931–4941.
13. Kim, J.O. and Weiser, J.N. 1997. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis.177, 368–377.
14. Liu, Y., Wang, H., Chen, M., Sun, Z., Zhao, R., Zhang, L., Zhang, H., Wang, L., Chu, Y., and Ni, Y. 2008. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in china younger than 5 years. Diagn. Microbiol. Infect. Dis.61, 256–263.
15. Montagnani, F., Fanetti, A., Stolzuoli, L., Croci, L., Arena, F., Zanchi, A., and Cellesi, C. 2008. Pneumococcal disease in a paediatric population in a hospital of central italy: A clinical and microbiological case series from 1992 to 2006. J. Infect.56, 179–184.
16. O’Brien, K. L., Wolfson, L.J., Watt, J.P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O.S., and Cherian, T. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet374, 893–902.
17. Sabharwal, V., Ram, S., Figueira, M., Park, I.H., and Pelton, S.I. 2009. Role of complement in host defense against pneumococcal otitis media. Infect. Immun.77, 1121–1127.
18. Shainheit, M.G., Mule, M., and Camilli, A. 2014. The core promoter of the capsule operon of Streptococcus pneumoniae is necessary for colonization and invasive disease. Infect. Immun.82, 694–705.
19. Skovsted, I.C., Kerrn, M.B., Sonne-Hansen, J., Sauer, L.E., Nielsen, A.K., Konradsen, H.B., Petersen, B.O., Nyberg, N.T., and Duus, J.O. 2007. Purification and structure characterization of the active component in the pneumococcal 22f polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays. Vaccine25, 6490–6500.
20. Smith, B.L. and Hostetter, M.K. 2000. C3 as substrate for adhesion of Streptococcus pneumoniae. J. Infect. Dis.182, 497–508.
21. Standish, A.J. and Weiser, J.N. 2009. Human neutrophils kill Streptococcus pneumoniae via serine proteases. J. Immunol.183, 2602–2609.
22. Tomasz, A. 1968. Biological consequences of the replacement of choline by ethanolamine in the cell wall of pneumococcus: Chain formation, loss of transformability, and loss of autolysis. Proc. Natl. Acad. Sci. USA59, 86–93.
23. Weidenmaier, C., Kokai-Kun, J.F., Kristian, S.A., Chanturiya, T., Kalbacher, H., Gross, M., Nicholson, G., Neumeister, B., Mond, J.J., and Peschel, A. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med.10, 243–245.
24. Weidenmaier, C. and Peschel, A. 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol.6, 276–287.
25. Weiser, J.N., Austrian, R., Sreenivasan, P.K., and Masure, H.R. 1994. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun.62, 2582–2589.
26. Weiser, J.N., Markiewicz, Z., Tuomanen, E.I., and Wani, J.H. 1996. Relationship between phase variation in colony morphology, intrastrain variation in cell wall phsiology, and nasopharyngeal colozition by Streptococcus pneumoniae. Infect. Immun.64, 2240–2246.
27. Wu, K., Huang, J., Zhang, Y., Xu, W., Xu, H., Wang, L., Cao, J., Zhang, X., and Yin, Y. 2014. A novel protein, RafX, is important for common cell wall polysaccharide biosynthesis in Streptococcus pneumoniae: Implications for bacterial virulence. J. Bacteriol.196, 3324–3334.